谷歌浏览器插件
订阅小程序
在清言上使用

Abstract P5-01-09: Establishment and Characterization of Two Simultaneously Developed T-DM1-resistant, ER+/HER2+ XPDX Models from the Same Patient with Differential in Vivo Sensitivity to Trastuzumab Deruxtecan (Ds-8201A)

Cancer Research(2022)

引用 0|浏览12
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要